Underlying Data
2171 CARSGEN-B
16.23
+0.280
(+1.75%)
Bid: 16.16
Ask: 16.23
15.98
32.53M
9.48B
16.50
15.95
2.02M
-80.8
15.71
15.89
500
0.00 %
57.25
10.02
15.98
15.95
32.53M
2.02M
9.48B
-80.8
16.50
15.71
500
0.00 %
57.25
10.02
15.89
Description: CARSGEN is a Chinese innovative pharmaceutical company focused on developing CAR-T cell therapies for the treatment of hematologic malignancies and solid tumors.
Industry: Pharma
Last Updated:12-06-26 11:00 (15 minutes delayed)
Similar Product
Information Provided by DB Power Online Limited
[Disclaimer]